DOCSLIB.ORG

A Anatomical Terms . Body Regions . . Abdomen . . . Groin

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Anatomical Terms . Body Regions . . Abdomen . . . Groin A ANATOMICAL TERMS . BODY REGIONS . ABDOMEN . GROIN . AXILLA . BACK . LUMBOSACRAL REGION . BREAST . BUTTOCKS . EXTREMITIES . AMPUTATION STUMPS . ARM . ELBOW . FOREARM . HAND . FINGERS . THUMB . SHOULDER . WRIST . LEG . ANKLE . FOOT . FOREFOOT . TOES . HALLUX . HEEL . METATARSUS . HIP . KNEE . THIGH . HEAD . EAR . VESTIBULE . FACE . EYE . CORNEA . MOUTH . JAW . TONGUE . TOOTH . NOSE . NECK . PHARYNX . PELVIS . PELVIC FLOOR . PERINEUM . SKIN . HAIR . NAILS . THORAX . TRUNK . CARDIOVASCULAR SYSTEM . BLOOD VESSELS . ARTERIES . AORTA . CAROTID ARTERIES . CORONARY VESSELS . PULMONARY ARTERY . VERTEBRAL ARTERY . MICROCIRCULATION . VEINS . CORONARY VESSELS . HEART . HEART VALVES . AORTIC VALVE . MITRAL VALVE . HEART VENTRICLE . MYOCARDIUM . CELLS . BLOOD CELLS . BLOOD PLATELETS . ERYTHROCYTES . LEUKOCYTES . BASOPHILS . LYMPHOCYTES . NEUTROPHILS . CELL MEMBRANE . SYNAPSES . CELL NUCLEUS . CELLS CULTURED . TUMOR CELLS CULTURED . CONNECTIVE TISSUE CELLS . CYTOPLASM . MITOCHONDRIA . EPITHELIAL CELLS . GERM CELLS . OVUM . SPERMATOZOA . MAST CELLS . NEUROGLIA . NEURONS . AXONS . NEURONS AFFERENT . NEURONS EFFERENT . MOTOR NEURONS . PHAGOCYTES . MACROPHAGES . DIGESTIVE SYSTEM . BILIARY TRACT . BILE DUCTS . GALLBLADDER . ESOPHAGUS . GASTROINTESTINAL TRACT . INTESTINES . ANAL CANAL . CECUM . COLON . DUODENUM . ILEUM . JEJUNUM . RECTUM . STOMACH . LIVER . PANCREAS . EMBRYONIC STRUCTURES . EMBRYO . FETUS . OVUM . PLACENTA . ENDOCRINE SYSTEM . ENDOCRINE GLANDS . ADRENAL GLANDS . PITUITARY GLAND . THYMUS GLAND . FLUIDS . BODY FLUIDS . BLOOD . CEREBROSPINAL FLUID . URINE . FECES . SECRETIONS . BILE . GASTRIC ACID . MUCUS . SALIVA . SPUTUM . SWEAT . SYNOVIAL FLUID . HEMIC AND IMMUNE SYSTEMS . BLOOD . BLOOD CELLS . BLOOD PLATELETS . ERYTHROCYTES . LEUKOCYTES . BASOPHILS . LYMPHOCYTES . NEUTROPHILS . HEMATOPOIETIC SYSTEM . IMMUNE SYSTEM . BLOOD PLATELETS . BONE MARROW . LEUKOCYTES . BASOPHILS . LYMPHOCYTES . NEUTROPHILS . LYMPHATIC SYSTEM . SPLEEN . MAST CELLS . PHAGOCYTES . MACROPHAGES . RETICULOENDOTHELIAL SYSTEM . MUSCULOSKELETAL SYSTEM . CARTILAGE . CARTILAGE ARTICULAR . INTERVERTEBRAL DISK . MENISCI TIBIAL . FASCIA . JOINTS . ANKLE JOINT . ATLANTO AXIAL JOINT . ATLANTO OCCIPITAL JOINT . ELBOW JOINT . HAND JOINTS . CARPAL JOINTS . FINGER JOINT . METACARPOPHALANGEAL JOINT . WRIST JOINT . HIP JOINT . KNEE JOINT . MENISCI TIBIAL . SACROILIAC JOINT . SHOULDER JOINT . SYNOVIAL FLUID . SYNOVIAL MEMBRANE . TARSAL JOINT . SUBTALAR JOINT . TEMPOROMANDIBULAR JOINT . TOE JOINT . METATARSOPHALANGEAL JOINT . LIGAMENTS . LIGAMENTS ARTICULAR . ANTERIOR CRUCIATE LIGAMENT . POSTERIOR CRUCIATE LIGAMENT . MUSCLES . MUSCLE FIBERS . MUSCLE SKELETAL . ABDOMINAL MUSCLES . FACIAL MUSCLES . NECK MUSCLES . QUADRICEPS MUSCLE . RESPIRATORY MUSCLES . DIAPHRAGM . MUSCLE SMOOTH . TENDONS . ACHILLES TENDON . ROTATOR CUFF . SKELETON . BONES . ARM BONES . CLAVICLE . HUMERUS . METACARPUS . SCAPULA . ULNA . EPIPHYSES . FACIAL BONES . FOOT BONES . METATARSAL BONES . TARSAL BONES . CALCANEUS . TALUS . TOE PHALANGES . HAND BONES . CARPAL BONES . LEG BONES . FEMUR . FEMUR HEAD . FEMUR NECK . FIBULA . PATELLA . TIBIA . PELVIC BONES . RIBS . SESAMOID BONES . SKULL . JAW . SPINE . CERVICAL VERTEBRAE . ATLAS . AXIS . ODONTOID PROCESS . INTERVERTEBRAL DISK . LUMBAR VERTEBRAE . SACRUM . SPINAL CANAL . THORACIC VERTEBRAE . STERNUM . NERVOUS SYSTEM . CENTRAL NERVOUS SYSTEM . BRAIN . BRAIN STEM . CEREBELLUM . CEREBRAL VENTRICLES . LIMBIC SYSTEM . HIPPOCAMPUS . PROSENCEPHALON . HYPOTHALAMUS . TELENCEPHALON . BASAL GANGLIA . CEREBRAL CORTEX . FRONTAL LOBE . MOTOR CORTEX . THALAMUS . TELENCEPHALON . BASAL GANGLIA . CEREBRAL CORTEX . FRONTAL LOBE . MOTOR CORTEX . MENINGES . SPINAL CORD . GANGLIA . NEURAL PATHWAYS . NEUROGLIA . NEURONS . NERVE FIBERS . AXONS . NEURONS AFFERENT . NEURONS EFFERENT . MOTOR NEURONS . PERIPHERAL NERVOUS SYSTEM . AUTONOMIC NERVOUS SYSTEM . PARASYMPATHETIC NERVOUS SYSTEM . SYMPATHETIC NERVOUS SYSTEM . NERVE ENDINGS . RECEPTORS SENSORY . MECHANORECEPTORS . PRESSORECEPTORS . PERIPHERAL NERVES . AUTONOMIC PATHWAYS . CRANIAL NERVES . ACCESSORY NERVE . ACOUSTIC NERVE . FACIAL NERVE . OPTIC NERVE . TRIGEMINAL NERVE . VAGUS NERVE . LARYNGEAL NERVES . SPINAL NERVES . BRACHIAL PLEXUS . MEDIAN NERVE . RADIAL NERVE . ULNAR NERVE . CERVICAL PLEXUS . PHRENIC NERVE . LUMBOSACRAL PLEXUS . FEMORAL NERVE . SCIATIC NERVE . PERONEAL NERVE . TIBIAL NERVE . SPINAL NERVE ROOTS . THORACIC NERVES . SYNAPSES . RESPIRATORY SYSTEM . BRONCHI . LARYNX . LUNG . NOSE . PARANASAL SINUSES . PHARYNX . TRACHEA . TISSUE . CONNECTIVE TISSUE . ADIPOSE TISSUE . EPITHELIUM . EXOCRINE GLANDS . MEMBRANES . SOFT TISSUE . UROGENITAL SYSTEM . GENITALIA . GENITALIA FEMALE . OVARY . CORPUS LUTEUM . UTERUS . VAGINA . GENITALIA MALE . PENIS . PROSTATE . TESTIS . URINARY TRACT . BLADDER . KIDNEY B ORGANISMS . ALGAE AND FUNGI . ALGAE . FUNGI . BASIDIOMYCOTA . REISHI . SHIITAKE MUSHROOMS . YEASTS . CANDIDA . ANIMALS . ANIMALS DOMESTIC . CATS . DOGS . INVERTEBRATES . ARTHROPODS . INSECTS . SPIDERS . HELMINTHS . PROTOZOA . SPONGES . VERTEBRATES . BIRDS . FISHES . MAMMALS . CATS . CATTLE . DOGS . HORSES . PRIMATES . HUMANS . RABBITS . RODENTS . MICE . RATS . SHEEP . REPTILES . BACTERIA . HELICOBACTER PYLORI . PLANTS . ALSTROEMERIA . ANTIRRHINUM . AQUILEGIA . ASTERACEAE . BACCHARIS . BEGONIACEAE . BROMUS . BUDDLEJA . CALYSTEGIA . CARTHAMUS . CARTHAMUS TINCTORIUS . CEANOTHUS . CENTAUREA . CESTRUM . CIRSIUM . CISTUS . CONVALLARIA . CONVOLVULUS . COREOPSIS . CROCUS . DAHLIA . DELPHINIUM . DROSERACEAE . ECHINOCHLOA . EICHHORNIA . ELEOCHARIS . EPHEDRA . EQUISETUM . ERIOGONUM . FORSYTHIA . GENISTA . GERANIUM . GOSSYPIUM . HEDERA . HEPATOPHYTA . HEUCHERA . HYACINTHUS . HYDRANGEA . ILEX . IPOMOEA . IRIS PLANT . ISATIS . JASMINUM . LAWSONIA PLANT . LONICERA . LUPINUS . MAGNOLIA . MIMOSA . NARCISSUS . NYCTAGINACEAE . OPUNTIA . ORNITHOGALUM . PACHYSANDRA . PANICUM . PASPALUM . PELARGONIUM . PETUNIA . PHYLLANTHUS . PLANT COMPONENTS . FLOWERING TOPS . FLOWERS . FRUIT . ANACARDIUM . ANANAS . ASIMINA . BERTHOLLETIA . CARICA . CARYA . CITRUS AURANTIIFOLIA . CITRUS PARADISI . CITRUS SINENSIS . COCOS . CORYLUS . FICUS . FRAGARIA . GARCINIA . ILLICIUM . JUGLANS . LITCHI . LYCOPERSICON ESCULENTUM . MACADAMIA . MANGIFERA . MORUS . MUSA . OLEA . PASSIFLORA . PSIDIUM . PUNICACEAE . PYRUS . RIBES . PLANT BARK . PLANT LEAVES . POLLEN . RHIZOME . ROOTS . SEEDS . PLANT PHYSIOLOGY . PLANTS EDIBLE . ADANSONIA . AGROPYRON . ALLIUM . ALLIUM CEPA . ALLIUM SATIVUM . ANACARDIUM . ANANAS . ANNONA . ARMORACIA . ARTOCARPUS . BAMBUSA . BARBAREA . BERTHOLLETIA . BRASSICACEAE . CAPPARIS . CARICA . CARYA . CEREALS . AVENA SATIVA . HORDEUM . ORYZA SATIVA . PENNISETUM . SECALE CEREALE . TRITICUM . ZEA MAYS . CINNAMOMUM . CINNAMOMUM AROMATICUM . CITRUS AURANTIIFOLIA . CITRUS PARADISI . CITRUS SINENSIS . COCOS . COFFEA . CORYLUS . CURCUMA . CURCUMA LONGA . CYAMOPSIS . CYMBOPOGON . CYNARA . CYNARA SCOLYMUS . FICUS . FRAGARIA . GARCINIA . GLYCYRRHIZA . HERBS . ACHILLEA . ACTAEA . ADOXACEAE . AGROSTEMMA . ALTHAEA . AMBROSIA . ANAGALLIS . ANGELICA . ANGELICA ARCHANGELICA . ANGELICA SINENSIS . ANTHEMIS . APOCYNUM . ARCTIUM . ARTEMISIA . ARTEMISIA ABSINTHIUM . ARTEMISIA ANNUA . ASCLEPIAS . BALLOTA . CARDAMINE . CELOSIA . CHAMOMILE . COMFREY . COPTIS . CORIANDRUM . ERYNGIUM . GENTIANA . HYDRASTIS . LEONURUS . LINARIA . LIPPIA . LYCHNIS . LYCOPUS . MATRICARIA . MENTHA . MENTHA PIPERITA . MENTHA PULEGIUM . MENTHA SPICATA . NIGELLA . NIGELLA DAMASCENA . NIGELLA SATIVA . OCIMUM BASILICUM . ONOPORDUM . ORIGANUM . PETASITES . PIPER . PIPER BITEL . PIPER NIGRUM . POLYGALA . POLYGONATUM . POLYGONUM . PRUNELLA . ROSMARINUS . SALVIA . SATUREJA . SIDERITIS . STACHYS . TANACETUM . TANACETUM PARTHENIUM . THALICTRUM . TRIGONELLA . VERONICA . ILLICIUM . JUGLANS . LEPIDIUM SATIVUM . LITCHI . LYCOPERSICON ESCULENTUM . MACADAMIA . MANGIFERA . MARANTACEAE . MORUS . MUSA . MYRTUS . NASTURTIUM . OLEA . PASSIFLORA . PSIDIUM . PUNICACEAE . PURUS . RIBES . RORIPPA . SACCHARUM . SCORZONERA . SESAMUM . SETARIA PLANT . SINAPIS . SOYBEANS . STEVIA . TRAGOPOGON . TROPAEOLUM . VACCINIUM . VANILLA . VEGETABLES . ASPARAGUS . CUCURBITA . DAUCUS CAROTA . RAPHANUS . SOLANUM MELONGENA . WASABIA . ZINGIBER OFFICINALE . PLANTS GENETICALLY MODIFIED . PLANTS MEDICINAL . ACHYROCLINE . ACONITUM . ADONIS . AGRIMONIA . ALCHEMILLA . ALOCASIA . ALOE . ALOE VERA . ARALIA . ARISTOLOCHIA . ARNICA . ARNICA MONTANA . ASTRAGALUS . BOSWELLIA . BRYONIA . CALENDULA . CAMELLIA SINENSIS . CANNABIS . CARDUUS . CIMICIFUGA . CINNAMOMUM . CINNAMOMUM AROMATICUM . COMBRETUM . COMMIPHORA . CROTON . CROTON OIL . CYPERUS . ECHINACEA . ECHINACEA PURPUREA . ERYSIMUM . EUPHORBIA . EUPHRASIA . FILIPENDULA . FRANGULA . GELSEMIUM . GINKGO BILOBA . GRINDELIA . HARPAGOPHYTUM . HELLEBORUS . HIBISCUS . HIPPOPHAE . HYPERICUM . HYPERICUM PERFORATUM . IPECACUANHA . LYCIUM . MAHONIA . MAYTENUS . MILK THISTLE . MOMORDICA . MOMORDICA CHARANTIA . MYRICA . OENOTHERA . OENOTHERA BIENNIS . PANAX . PANAX GINSENG . PHYSALIS . PICRORHIZA . PICRORHIZA KURROA . POLYPODIUM . PUERARIA . PULSATILLA . PYGEUM . QUILLAJA . REHMANNIA . RHODIOLA . RUMEX . RUTA . RUTA GRAVEOLENS . SCROPHULARIA . SCUTELLARIA . SCUTELLARIA BAICALENSIS . SENNA PLANT . SERENOA . SINAPIS . SMILAX . SOPHORA . TARAXACUM . TAXUS . TERMINALIA . TRIPTERYGIUM . TUSSILAGO . URTICA DIOICA . VACCARIA . VERBENA . VISCUM . VISCUM ALBUM . WITHANIA . WITHANIA SOMNIFERA . WOODFORDIA . XANTHIUM . PLANTS TOXIC . ATROPA . ATROPA BELLADONNA . DATURA . DATURA STRAMONIUM . HYOSCYAMUS . LABURNUM . NERIUM . PLATYCODON . POA . POTENTILLA . PRIMULA . PTERIDIUM . PTERIS . PYRACANTHA . RATIBIDA . RUDBECKIA . RUSCUS . SCOLYMUS . SEDUM . SEEDLING . SMILACINA . SOLANUM . SOLANUM GLAUCOPHYLLUM . SOLANUM MELONGENA . SOLANUM NIGRUM . SOLIDAGO . SONCHUS . SPARTIUM . STRIGA . TRADESCANTIA . TREES . ACERACEAE . AESCULUS . ANACARDIUM . ARTOCARPUS . ASIMINA . AVICENNIA . AZADIRACHTA . AZADIRACHTA INDICA . BERTHOLLETIA . BETULA . BOMBACACEAE . ADANSONIA . BUXUS . CALOPHYLLUM . CARICA . CARYA . CEIBA . CITRUS AURANTIIFOLIA . CITRUS PARADISI . CITRUS SINENSIS . COCOS . CONIFEROPHYTA . CORYLUS . CRATAEGUS . CRYPTOMERIA . CUNNINGHAMIA . FICUS . FRAXINUS . GARCINIA . JUGLANS ..
Load more

Recommended publications
  • Programme & Abstracts
    The 57th Annual Meeting of the International Association of Forensic Toxicologists. 2nd - 6th September 2019 BIRMINGHAM, UK The ICC Birmingham Broad Street, Birmingham B1 2EA Programme & Abstracts 1 Thank You to our Sponsors PlatinUm Gold Silver Bronze 2 3 Contents Welcome message 5 Committees 6 General information 7 iCC maps 8 exhibitors list 10 Exhibition Hall 11 Social Programme 14 opening Ceremony 15 Schedule 16 Oral Programme MONDAY 2 September 19 TUESDAY 3 September 21 THURSDAY 5 September 28 FRIDAY 6 September 35 vendor Seminars 42 Posters 46 oral abstracts 82 Poster abstracts 178 4 Welcome Message It is our great pleasure to welcome you to TIAFT Gala Dinner at the ICC on Friday evening. On the accompanying pages you will see a strong the UK for the 57th Annual Meeting of scientific agenda relevant to modern toxicology and we The International Association of Forensic thank all those who submitted an abstract and the Toxicologists Scientific Committees for making the scientific programme (TIAFT) between 2nd and 6th a success. Starting with a large Young Scientists September 2019. Symposium and Dr Yoo Memorial plenary lecture by Prof Tony Moffat on Monday, there are oral session topics in It has been decades since the Annual Meeting has taken Clinical & Post-Mortem Toxicology on Tuesday, place in the country where TIAFT was founded over 50 years Human Behaviour Toxicology & Drug-Facilitated Crime on ago. The meeting is supported by LTG (London Toxicology Thursday and Toxicology in Sport, New Innovations and Group) and the UKIAFT (UK & Ireland Association of Novel Research & Employment/Occupational Toxicology Forensic Toxicologists) and we thank all our exhibitors and on Friday.
    [Show full text]
  • Cross Reaction Guide
    Individual Reaction Key Methadone(MTD) Phencyclidine(PCP) Amphetamines(AMP) Tricyclic Antidepressants(TCA) Oxycodone(OXY) Barbiturates(BAR) Methamphetamines(MET) Benzodiazepines(BZO) Tramadol(TML) Opiates(OPI, MOP, MOR) Marijuana(THC) Ecstasy(MDMA) Cotinine(COT) Cocaine(COC) Buprenorphine(BUP) Propoxyphene(PPX) Non-reactive Multiple Reaction Key MET and AMP OPI and OXY MDMA and MET MDMA and AMP MET and TCA Generic Name of Compound Trade Name of Compound Results 6-Acetylmorphine N/A Positive: Opiates(OPI, MOP, MOR) Aceta, Acephen, Apacet, Dapacen, Feverall, Acetaminophen (aka Paracetamol) Tylenol, Excedrin (combination), Panadol, Non-reactive Tempra Acetaminophen with Codeine (aka Positive: Opiates(OPI, MOP, MOR) Tylenol 3, Tylenol with Codeine Paracetamol with Codeine) Potential reactants: Dihydrocodeine Acetophenetidin Phenacetin Non-reactive Aspirin, Anadin, Anasin, Bufferin, Caprin, Acetylsalicyclic Acid Disprin, Ecotrin, Empirin, Excedrin Non-reactive (combination) Allobarbital N/A Positive: Barbiturates(BAR) Alphenol N/A Positive: Barbiturates(BAR) Positive: Benzodiazepines(BZO) Potential Alprazolam Xanax reactants: Oxaprozin (Daypro), Sertraline Aluminum Chloride Hexahydrate Drichlor, Anhydrol Forte Non-reactive Alu-Cap, Alisone, Gastrocote, Kolanticon, Aluminum Hydroxide Non-reactive Maalox TC, Mucogel, Pyrogastrone, Topal Alverine Citrate Spasmonal, Spasmonal Fibre Non-reactive Amantadine Symmetrel Positive: Amphetamines(AMP) SpearesMedical.comAminopyrine N/A Non-reactive Elavil, Lentizol, Tryptizol, Triptafen, Triptafen- Amitriptyline
    [Show full text]
  • References to Argentina
    References to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES The Americas (pages 12 to 14 WDR 13) In the Americas, a high prevalence of most illicit drugs, essentially driven by estimates in North America, was observed, with the prevalence of cannabis (7.9 per cent) and cocaine (1.3 per cent) being particularly high in the region. South America, Central America and the Caribbean The annual prevalence of cocaine use in South America (1.3 per cent of the adult population) is comparable to levels in North America, while it remains much higher than the global average in Central America (0.6 per cent) and the Caribbean (0.7 per cent). Cocaine use has increased significantly in Brazil, Costa Rica and, to lesser extent, Peru while no change in its use was reported in Argentina. The use of cannabis in South America is higher (5.7 per cent) than the global average, but lower in Central America and Caribbean (2.6 and 2.8 per cent respectively). In South America and Central America the use of opioids (0.3 and 0.2 per cent, respectively) and Ecstasy (0.1 per cent each) also remain well below the global average. While opiates use remains low, countries such as Colombia report that heroin use is becoming increasingly common among certain age groups and socio-economic classes.30 Part 2 NEW PSYCHOACTIVE SUBSTANCES C. THE RECENT EMERGENCE AND SPREAD OF NEW PSYCHOACTIVE SUBSTANCES (page 67 WDR 13) Spread at the global level Number of countries reporting the emergence of new psychoactive substances Pursuant to Commission on Narcotic Drugs resolution 55/1, entitled “Promoting international cooperation in responding to the challenges posed by new psychoactive substances”, in 2012 UNODC sent a questionnaire on NPS to all Member States, to which 80 countries and territories replied.
    [Show full text]
  • Paradigm Evolution of the Traditional Chinese Medicine and Its Application in International Community
    Central Annals of Community Medicine and Practice Case Study *Corresponding author Hui Yang, Department of Primary Health Care, Monash Paradigm Evolution of the University Australia, Melbourne, Australia, Email: Submitted: 14 July 2015 Traditional Chinese Medicine Accepted: 14 August 2015 Published: 16 August 2015 Copyright and its Application in © 2015 Yang et al. International Community OPEN ACCESS 1,2 2 3 4 Keywords Minmei He , Hui Yang *, Shane Thomas , Colette Browning , • Traditional chinese medicine Kendall Searle2 and Wentian Lu5 and Tao Li1 • Paradigm evolution 1Department of Health Services, Beijing University of Chinese Medicine, China • Classification 2Department of Primary Health care, Monash University, Australia • Application 3The University of Adelaide, Australia 4Royal District Nursing Service Australia, Australia 5University College London, UK Abstract Objective: This paper aims to explore the definition, historical development, category and international application of TCM to help the world understand the TCM better. Method: The research searched the database of CNKI (China National Knowledge Infrastructure), web of WHO and the textbook related with TCM by the keywords such as ‘Traditional Chinese Medicine’, ‘Traditional Medicine’, ‘history’, ‘utilization’, ‘classification’, and analyzed the material and made a conclusion. Result: The term of Traditional Chinese Medicine (TCM) was named after the People’s Republic of China was set up; The four famous works built up the fundamental of theory and ideology of medicine in China, which are ‘Huang Di Nei Jing’, ‘Nan Jing’, ‘Shen Nong Bai Cao Jing’ and ‘Shang Han Zai Bing Lun’; The paper classified TCM into two different ways, one is based on the theory difference, the other is based on the life cycle of disease; TCM is well accepted by the world with its effectiveness.
    [Show full text]
  • Chiro 19-2.Indd
    THE CHIROPR ACTIC REPORT www.chiropracticreport.com Editor: David Chapman-Smith LL.B. (Hons.) March 2005 Vol. 19 No. 2 THE CHIROPRACTIC PROFESSION Basic Facts, Independent Evaluations, Common Questions Answered “The chiropractic profession is assuming ing the UK,2 US,3 Denmark4 and New its valuable and appropriate role in the Zealand,5 and most recently European health care system in this country and guidelines,6 have endorsed the traditional around the world. As this happens the chiropractic approach to management professional battles of the past will fade by recommending spinal manipulation and the patient at last will be the true and early activity for most patients. The winner.” expert panels for these guidelines, pre- Wayne Jonas, MD, Director (1995-1998), dominantly medical experts, have also Office of Alternative Medicine, US included chiropractors. National Institutes of Health, Bethesda, Large multicentre trials supported by the MD.1 British Medical Research Council and published by the British Medical Journal A. INTRODUCTION have reported that chiropractic manage- ment and skilled manipulation are more HIROPRACTIC (Greek: treatment by hand) arose as a separate profes- effective and cost-effective than usual or C 7, 8 sion in the United States in the 1890s. In best medical care. A UK Royal College of General Practitioners’ guideline for the Table 1 that era of heroic medicine many alterna- tive disciplines emerged—chiropractic management of back pain, developed in Recent Developments in the Chiropractic World has been the strongest survivor. partnership with the British Chiropractic • In the US, new federal legislation during 2002 Association, recommends to GPs that, in to 2004 has introduced and funded chiropractic Through to the 1950s the chiropractic the absence of certain red flags, they con- services in the military and veterans’ administra- profession remained in its early develop- tion health care systems, and expanded services for sider referrals of patients with back pain ment stages—it was isolated, controver- 9 seniors under Medicare.
    [Show full text]
  • HANDBOOK of Medicinal Herbs SECOND EDITION
    HANDBOOK OF Medicinal Herbs SECOND EDITION 1284_frame_FM Page 2 Thursday, May 23, 2002 10:53 AM HANDBOOK OF Medicinal Herbs SECOND EDITION James A. Duke with Mary Jo Bogenschutz-Godwin Judi duCellier Peggy-Ann K. Duke CRC PRESS Boca Raton London New York Washington, D.C. Peggy-Ann K. Duke has the copyright to all black and white line and color illustrations. The author would like to express thanks to Nature’s Herbs for the color slides presented in the book. Library of Congress Cataloging-in-Publication Data Duke, James A., 1929- Handbook of medicinal herbs / James A. Duke, with Mary Jo Bogenschutz-Godwin, Judi duCellier, Peggy-Ann K. Duke.-- 2nd ed. p. cm. Previously published: CRC handbook of medicinal herbs. Includes bibliographical references and index. ISBN 0-8493-1284-1 (alk. paper) 1. Medicinal plants. 2. Herbs. 3. Herbals. 4. Traditional medicine. 5. Material medica, Vegetable. I. Duke, James A., 1929- CRC handbook of medicinal herbs. II. Title. [DNLM: 1. Medicine, Herbal. 2. Plants, Medicinal.] QK99.A1 D83 2002 615′.321--dc21 2002017548 This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted with permission, and sources are indicated. A wide variety of references are listed. Reasonable efforts have been made to publish reliable data and information, but the author and the publisher cannot assume responsibility for the validity of all materials or for the consequences of their use. Neither this book nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, microfilming, and recording, or by any information storage or retrieval system, without prior permission in writing from the publisher.
    [Show full text]
  • Effect of Bloodletting Therapy at Local Myofascial Trigger
    Online Submissions: http://www.journaltcm.com J Tradit Chin Med 2016 February 15; 36(1): 26-31 [email protected] ISSN 0255-2922 © 2016 JTCM. All rights reserved. CLINICAL STUDYTOPIC Effect of bloodletting therapy at local myofascial trigger points and acupuncture at Jiaji (EX-B 2) points on upper back myofascial pain syndrome: a randomized controlled trial Jiang Guimei, Jia Chao, Lin Mode aa Jiang Guimei, Physiotherapy Department, Guangdong Pro- control group (n = 33) were treated with a lidocaine vincial Hospital of Traditional Chinese Medicine, Guangzhou block at trigger points; one treatment course con- 510120, China sisted of five sessions of lidocaine block therapy Jia Chao, Tuina Department, No.1 Affiliated Hospital of with a 2-day break between each session. The sim- Guangzhou University of TCM, Guangzhou 510405, China plified McGill Scale (SF-MPQ) and tenderness Lin Mode, Department of Acupuncture and Moxibustion, Guangdong Provincial Hospital of TCM, Guangzhou 510120, threshold determination were used to assess pain China before and after a course of treatment. Supported by the Science and Technology Plan Project of RESULTS: After the third and fifth treatment, the Social Development of Guangdong Provincial Department of Science and Technology (Project name: Effect of Bloodlet- SF-MPQ values were significantly decreased (P < ting Therapy at Local Myofascial Trigger Points and Acu- 0.01) and the tenderness thresholds were signifi- puncture at Jiaji Points on Upper Back Myofascial Pain Syn- cantly increased (P < 0.01) in both groups com- drome, No. 2011B080701089) pared with before treatment. There were no signifi- Correspondence to: Associate chief physician Jia Chao, cant differences in pain assessments between the Tuina Department, No.1 Affiliated Hospital of Guangzhou two groups after three and five treatments (P > University of TCM, Guangzhou 510405, China.
    [Show full text]
  • The Medical Perspective of Cupping Therapy: Effects and Mechanisms of Action
    Journal of Traditional and Complementary Medicine 9 (2019) 90e97 Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier.com/locate/jtcme The medical perspective of cupping therapy: Effects and mechanisms of action * Abdullah M.N. Al-Bedah a, Ibrahim S. Elsubai a, , Naseem Akhtar Qureshi a, Tamer Shaban Aboushanab a, Gazzaffi I.M. Ali a, Ahmed Tawfik El-Olemy a, b, Asim A.H. Khalil a, Mohamed K.M. Khalil a, Meshari Saleh Alqaed a a National Center of Complementary and Alternative Medicine, Ministry of Health, Riyadh 11662, Saudi Arabia b Public Health and Community Medicine Department, Faculty of Medicine, Tanta University, Egypt article info abstract Article history: Cupping Therapy (CT) is an ancient method and currently used in the treatment of a broad range of Received 25 July 2017 medical conditions. Nonetheless the mechanism of action of (CT) is not fully understood. This review Accepted 12 March 2018 aimed to identify possible mechanisms of action of (CT) from modern medicine perspective and offer Available online 30 April 2018 possible explanations of its effects. English literature in PubMed, Cochrane Library and Google Scholar was searched using key words. Only 223 articles identified, 149 records screened, and 74 articles Keywords: excluded for irrelevancy. Only 75 full-text articles were assessed for eligibility, included studies in this Cupping review were 64. Six theories have been suggested to explain the effects produced by cupping therapy. Hijama “ Mechanisms of action Pain reduction and changes in biomechanical properties of the skin could be explained by Pain-Gate ” “ ” “ fl ” Effects Theory , Diffuse Noxious Inhibitory Controls and Re ex zone theory .
    [Show full text]
  • Proposed Changes to the 2021 FEI Equine Prohibited Substances List (EPSL) (Effective from 01.01.2022)
    Proposed changes to the 2021 FEI Equine Prohibited Substances List (EPSL) (effective from 01.01.2022) SUBSTANCE NAME CURRENT PROPOSED COMMENT STATUS EPSL CATEGORY ACETYLCHOLINESTERASE INHIBITOR Used in the treatment of Edrophonium Controlled Banned myasthenia gravis and Medication Substance has no legitimate use in the treatment of sports horses Used to increase Huperzine A Unlisted Banned alertness and treat Substance myasthenia gravis. The substance has no legitimate use in the treatment of sports horses. AMIDES Palmitoylethanolamid Banned Controlled Used in the treatment of Substance Medication joint pain ANGIOTENSIN CONVERTING ENZYME INHIBITORS Enalapril Controlled Banned The substance carries a Medication Substance high risk of abuse and has no legitimate use in the sports horse Enalaprilat Controlled Banned The substance carries a Medication Substance high risk of abuse and has no legitimate use in the sports horse Lisinopril Controlled Banned The substance carries a Medication Substance high risk of abuse and has no legitimate use in the sports horse Moexipril Controlled Banned The substance carries a Medication Substance high risk of abuse and has no legitimate use in the sports horse 1 Perindoprilat Controlled Banned The substance carries a Medication Substance high risk of abuse and has no legitimate use in the sports horse ANTIHISTAMINES Antazoline Controlled Banned The substance has no Medication Substance legitimate use in the sports horse Azatadine Controlled Banned The substance has Medication Substance sedative effects
    [Show full text]
  • A Critical Appraisal of Evidence and Arguments Used by Australian Chiropractors to Promote Therapeutic Interventions
    A CRITICAL APPRAISAL OF EVIDENCE AND ARGUMENTS USED BY AUSTRALIAN CHIROPRACTORS TO PROMOTE THERAPEUTIC INTERVENTIONS Ken Harvey1 MB BS, FRCPA 1 Adjunct Associate Professor Department of Epidemiology and Preventive Medicine School of Public Health and Preventive Medicine Monash University The Alfred Centre 99 Commercial Road Melbourne VIC 3004 Appraisal of Evidence Harvey A CRITICAL APPRAISAL OF EVIDENCE AND ARGUMENTS USED BY AUSTRALIAN CHIROPRACTORS TO PROMOTE THERAPEUTIC INTERVENTIONS ABSTRACT The Australian Health Practitioner Regulation Agency is currently dealing with over 600 complaints about chiropractors. Common allegations in these complaints are that chiropractic adjustments are promoted for pregnant women, infants and children despite the lack of good evidence to justify many of these interventions. The majority of chiropractors complained about appear to be caring practitioners who genuinely believe that the interventions they promote are effective. However, belief based on disproven dogma, the selective use of poor-quality evidence, and personal experience subject to bias is no longer an appropriate basis on which to promote and practice therapeutic interventions. Nor should treatments be justified solely on the basis of possible placebo effect. This paper provides a critical analysis of some of the evidence and arguments used by chiropractors to justify treatments that have been the subject of complaints. This analysis amplifies the recent statement on advertising by the Chiropractic Board of Australia. It should assist practitioners to understand the difference between the high-level evidence required by the Board and the low-level evidence used by some practitioners to justify their promotion and practice. It supports efforts by the Chiropractors' Association of Australia to encourage more research.
    [Show full text]
  • Hippocrates Now
    Hippocrates Now 35999.indb 1 11/07/2019 14:48 Bloomsbury Studies in Classical Reception Bloomsbury Studies in Classical Reception presents scholarly monographs offering new and innovative research and debate to students and scholars in the reception of Classical Studies. Each volume will explore the appropriation, reconceptualization and recontextualization of various aspects of the Graeco- Roman world and its culture, looking at the impact of the ancient world on modernity. Research will also cover reception within antiquity, the theory and practice of translation, and reception theory. Also available in the Series: Ancient Magic and the Supernatural in the Modern Visual and Performing Arts, edited by Filippo Carlà & Irene Berti Ancient Greek Myth in World Fiction since 1989, edited by Justine McConnell & Edith Hall Antipodean Antiquities, edited by Marguerite Johnson Classics in Extremis, edited by Edmund Richardson Frankenstein and its Classics, edited by Jesse Weiner, Benjamin Eldon Stevens & Brett M. Rogers Greek and Roman Classics in the British Struggle for Social Reform, edited by Henry Stead & Edith Hall Homer’s Iliad and the Trojan War: Dialogues on Tradition, Jan Haywood & Naoíse Mac Sweeney Imagining Xerxes, Emma Bridges Julius Caesar’s Self-Created Image and Its Dramatic Afterlife, Miryana Dimitrova Once and Future Antiquities in Science Fiction and Fantasy, edited by Brett M. Rogers & Benjamin Eldon Stevens Ovid’s Myth of Pygmalion on Screen, Paula James Reading Poetry, Writing Genre, edited by Silvio Bär & Emily Hauser
    [Show full text]
  • LEGISLATIVE ASSEMBLY Question on Notice
    LEGISLATIVE ASSEMBLY Question On Notice Thursday, 15 February 2018 2560. Ms M. M Quirk to the Minister for Police; I refer to the commencement of operation of the Road Traffic Amendment Act 2016 in March 2017 which introduced compulsory blood or urine samples to be taken from drivers involved in serious crashes, and I ask: (a) since March 2017 how many such samples have been taken; (b) for what specific substances are those blood or urine samples tested; (c) what are the results of those tests to date; and (d) what percentage of drivers have been found to have ingested more than one substance capable of impairing driving skills? Answer (a) The compulsory taking of blood from all drivers involved in serious crashes commenced on 10 March 2017. Between 10 March 2017 and 22 February 2018 (inclusive) a total of 398 blood test samples have been collected under the provision of the Road Traffic Amendment Act 2016. There have been no urine tests collected. (b) Please see attached table for a list of substances in blood sample that are identifiable in ChemCentre toxicology analysis (Paper Number). (c) Of the 398 blood samples collected, 48 are pending results of ChemCentre analysis. Of the 350 analysed, 259 samples had a specific substance(s) detected and 91 samples had no specific substance detected. d) Of the 259 samples with specific substance(s) detected, 92% were found to have multiple substances (more than one). Detectable Substances in Blood Samples capable of identification by the ChemCentre WA. ACETALDEHYDE AMITRIPTYLINE/NORTRIPTYLINE
    [Show full text]